PRIME GRANT

IDSEP230065

Cooperative Agreement

OVERVIEW

Awardee
Evonik Corporation
Government Description
DOD TRANSFER AWARDS
Grant Program (CFDA)
93.360 - Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development
Awarding / Funding Agency
HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]
Place of Performance
New Jersey United States
Geographic Scope
State-Wide
Related Opportunity
EP-IDS-23-002
Notes
Amendment Since initial award the total obligations have decreased 50% from $292,637,680 to $146,318,840.
Evonik Corporation was awarded Cooperative Agreement IDSEP230065 worth $146,318,840 from the HHS Office of the Assistant Secretary for Preparedness and Response in April 2023. The grant has a duration of 12 years 1 months and was awarded through assistance program 93.360 Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development.

STATUS
(Ongoing)

Last Modified 5/19/23

Period of Performance
4/1/23
Start Date
5/18/35
End Date
1.0% Complete

Funding Split
$146.3M
Federal Obligation
$0.0
Non-Federal Obligation
$146.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

ACTIVITY TIMELINE

TRANSACTION HISTORY

Modifications to IDSEP230065

ADDITIONAL DETAIL

Award ID FAIN
IDSEP230065
SAI Number
IDSEP230065-3359134870
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Awarding Office
75APRR ASPR OFFICE OF RESOURCE MANAGEMENT
Funding Office
75AN00 ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Performance District
NJ-90
Senators
Robert Menendez
Cory Booker
Modified: 5/19/23